Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Clicks GroupCLCGY +1.96%83 Debt-to-Equity is 0.73 as of Feb. 2026, which is 35% above its 10-year median of 0.54. GuruFocus rates CLCGY with a GF Score™ of 83/100 and a GF Value™ of $50.06 (Significantly Undervalued). Among 557 Healthcare Providers & Services companies, Clicks Group ranks worse than 65.71% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Clicks Group's Debt-to-Equity or its related term are showing as below:
CLCGY'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0.05 Med: 0.54 Max: 0.73
Current: 0.73
During the past 13 years, the highest Debt-to-Equity Ratio of Clicks Group was 0.73. The lowest was 0.05. And the median was 0.54.
CLCGY's Debt-to-Equity is ranked worse than 65.71% of 557
companies
in the Healthcare Providers & Services industry
Industry Median: 0.41
vs CLCGY: 0.73
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Clicks Group Debt-to-Equity Related Terms
Clicks Group Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for Clicks Group's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Clicks Group's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Clicks Group Debt-to-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Clicks Group's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Clicks Group's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Clicks Group (CLCGY) has a Debt-to-Equity of 0.73 as of Feb. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Clicks Group and its competitors. This is 35% above median its historical median of 0.54. Over the past decade, Clicks Group's Debt-to-Equity has ranged from 0.05 to 0.73. According to the industry distribution chart, Clicks Group ranks #366 out of 557 companies in the Healthcare Providers & Services industry, placing it in the top 65.7%.
Is Clicks Group's Debt-to-Equity too high?
Clicks Group's current Debt-to-Equity of 0.73 is 35% above median its 10-year median of 0.54. Over the past 10 years, this metric has ranged from a low of 0.05 to a high of 0.73. The Healthcare Providers & Services industry median Debt-to-Equity is 0.41. Clicks Group's value of 0.73 is 78% above this industry median. Based on the distribution chart, Clicks Group ranks #366 out of 557 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Clicks Group has a GF Score™ of 83/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Clicks Group's Debt-to-Equity compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Clicks Group ranks #366 out of 557 companies for Debt-to-Equity. This places Clicks Group in the lower half of its industry. The industry median Debt-to-Equity is 0.41. Clicks Group's value of 0.73 is 78% above this benchmark. Historically, Clicks Group's own Debt-to-Equity has ranged from 0.05 to 0.73 over the past decade. While the company's 10-year median is 0.54 vs. the industry median of 0.41, Clicks Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Healthcare Providers & Services company?
The median Debt-to-Equity among Healthcare Providers & Services companies is 0.41, based on 557 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Clicks Group's current Debt-to-Equity of 0.73 is 78% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Clicks Group and its competitors. For the Healthcare Providers & Services industry, the median Debt-to-Equity is 0.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Clicks Group's current Debt-to-Equity is 0.73, which is 35% above median its own 10-year median of 0.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clicks Group stock overvalued right now?
Based on GuruFocus' analysis, Clicks Group (CLCGY) is currently considered Significantly Undervalued. The stock's GF Value™ is $50.06, compared to a current price of $26.89 — trading 46.3% below its estimated fair value. The current Debt-to-Equity is 0.73, which is 35% above median its 10-year median of 0.54 and 78% above the Healthcare Providers & Services industry median of 0.41. Clicks Group's overall GF Score™ is 83/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Clicks Group (CLCGY), the current Debt-to-Equity is 0.73 as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Clicks Group (CLCGY) Overvalued in 2026?
Based on GuruFocus' analysis, Clicks Group stock appears to be undervalued.
The current stock price of $26.89 is trading 46.3% below its estimated GF Value™ of $50.06.
GuruFocus considers Clicks Group to be Significantly Undervalued.
Key valuation signals for CLCGY:
Debt-to-Equity: 0.73 (35% above median its 10-year median of 0.54)
GF Value™: $50.06 vs. price of $26.89 (46.3% below fair value)
Industry Position: 78% above the Healthcare Providers & Services median (#366 of 557)
No single metric tells the full story. See the CLCGY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Clicks Group Ltd operates prominently in health, beauty, and wellness retail across southern Africa. The company predominantly operates a retail pharmacy chain in South Africa, with a limited number of operations in bordering countries. The company has a portfolio of retail franchise brands including The Body Shop, M-Kem, and Sorbet among others. The company's business segments include Retail and Distribution. The company generates revenue from in-store and online sales of health, beauty, and wellness items, plus wholesale pharmaceutical distribution. Geographically, the maximum revenue is generated from South Africa.
83GF Score
Get the complete analysis for CLCGY
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CLCGY has been successfully added to your 
